AbbVie announced positive topline results from its pivotal Phase III TEMPO-2 trial, evaluating tavapadon as a flexible-dose (5mg to 15mg, once daily) monotherapy in early Parkinson's disease (PD).

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the appointment of ...

AI Powered Blood Test Detects Earliest Stage of Breast Cancer: Study FindsA new screening method that combines laser analysis ...

Intermittent fasting can be an excellent tool for weight loss, managing blood sugar levels, and improving cardiovascular ...

As we navigate the intricate maze of mesothelioma trials in California, it is essential to understand the legal landscape in ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN).

Vitamin D regulates hormones, reduces menstrual pain, supports fetal development and preserves bone health during menopause.

The Autoimmune Protocol (AIP) diet is an elimination diet designed to help reduce inflammation, manage symptoms and improve ...

Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Krystal Biotech (KRYS – Research Report) and keeping the price target ...

More patients referred for nAMD treatment via an optometry-led pathway receive timely care than those referred through a national system.

Drug discovery& development includes several processes and phases that demand a huge amount of funds ... drug optimization and repurposing, preclinical and clinical testing, and others), and end-user ...